Following the extraordinary general meeting's resolution to adopt a new articles of association, the Swedish Companies Registration Office (Swe: Bolagsverket) has approved the company's submission, after which Nasdaq has approved the application to change the name of the company. The first day of trading will take place today,
The new name reflects the company's ambition to be a long-term owner of profitable companies operating in the healthcare sector. The businesses and the decision-making are intended to take place in the independent subsidiaries.
For more information contact:
Email: erik.hedlund@nolsterbyinvest.se
Phone: +46 70-382 08 41
About
The following trademarks are owned and protected by
Further information regarding the company is available at https://pharmacolog.com/.
The company's Certified Adviser is
https://news.cision.com/perpetua-medical-ab/r/perpetua-medical-ab--formerly-pharmacolog-i-uppsala-ab--announces-its-first-day-of-trading-on-nasdaq,c3965578
https://mb.cision.com/Main/12317/3965578/2750439.pdf
https://news.cision.com/perpetua-medical-ab/i/perpetua-medical-logo-horizontal-anv,c3292138
(c) 2024 Cision. All rights reserved., source